Jian Z - Search Results

1

Anterior gradient 2 is a novel pro-tumor factor in pancreatic cancer under NF-κB subunit RelA trans-regulation that can be suppressed by eugenic acid.

Huang L, Yang C, Wang Y, Li G, Pan J, Luo H, Wu Z, Tian Y, Chen S, Chen J, Jian Z. Huang L, et al. Among authors: jian z. Biomed Pharmacother. 2020 Dec;132:110830. doi: 10.1016/j.biopha.2020.110830. Epub 2020 Oct 12. Biomed Pharmacother. 2020. PMID: 33059262 Free article.

2

miR-216a may inhibit pancreatic tumor growth by targeting JAK2.

Hou BH, Jian ZX, Cui P, Li SJ, Tian RQ, Ou JR. Hou BH, et al. FEBS Lett. 2015 Aug 4;589(17):2224-32. doi: 10.1016/j.febslet.2015.06.036. Epub 2015 Jul 3. FEBS Lett. 2015. PMID: 26149212 Free article.

3

MiR-204 regulates HMGA2 expression and inhibits cell proliferation in human thyroid cancer.

Wu ZY, Wang SM, Chen ZH, Huv SX, Huang K, Huang BJ, Du JL, Huang CM, Peng L, Jian ZX, Zhao G. Wu ZY, et al. Among authors: jian zx. Cancer Biomark. 2015;15(5):535-42. doi: 10.3233/CBM-150492. Cancer Biomark. 2015. PMID: 26406941

4

CXCL7 promotes proliferation and invasion of cholangiocarcinoma cells.

Guo Q, Jian Z, Jia B, Chang L. Guo Q, et al. Among authors: jian z. Oncol Rep. 2017 Feb;37(2):1114-1122. doi: 10.3892/or.2016.5312. Epub 2016 Dec 12. Oncol Rep. 2017. PMID: 27959418

5

SIRT5 promotes cell proliferation and invasion in hepatocellular carcinoma by targeting E2F1.

Chang L, Xi L, Liu Y, Liu R, Wu Z, Jian Z. Chang L, et al. Among authors: jian z. Mol Med Rep. 2018 Jan;17(1):342-349. doi: 10.3892/mmr.2017.7875. Epub 2017 Oct 25. Mol Med Rep. 2018. PMID: 29115436

6

miR-501 acts as an independent prognostic factor that promotes the epithelial-mesenchymal transition through targeting JDP2 in hepatocellular carcinoma.

Yu W, Deng W, Zhao Q, Zhuang H, Zhang C, Jian Z. Yu W, et al. Among authors: jian z. Hum Cell. 2019 Jul;32(3):343-351. doi: 10.1007/s13577-019-00243-7. Epub 2019 Mar 15. Hum Cell. 2019. PMID: 30877624

7

Prognostic value of tumor-associated macrophages in pancreatic cancer: a meta-analysis.

Yu M, Guan R, Hong W, Zhou Y, Lin Y, Jin H, Hou B, Jian Z. Yu M, et al. Among authors: jian z. Cancer Manag Res. 2019 May 3;11:4041-4058. doi: 10.2147/CMAR.S196951. eCollection 2019. Cancer Manag Res. 2019. PMID: 31118813 Free PMC article. Review.

8

miR-186 modulates hepatocellular carcinoma cell proliferation and mobility via targeting MCRS1-mediated Wnt/β-catenin signaling.

Wang H, Ou J, Jian Z, Ou Y. Wang H, et al. Among authors: jian z. J Cell Physiol. 2019 Dec;234(12):23135-23145. doi: 10.1002/jcp.28878. Epub 2019 May 29. J Cell Physiol. 2019. PMID: 31140612

9

METTL3 expression is associated with glycolysis metabolism and sensitivity to glycolytic stress in hepatocellular carcinoma.

Lin Y, Wei X, Jian Z, Zhang X. Lin Y, et al. Among authors: jian z. Cancer Med. 2020 Apr;9(8):2859-2867. doi: 10.1002/cam4.2918. Epub 2020 Feb 18. Cancer Med. 2020. PMID: 32068977 Free PMC article.

10

MicroRNA-33b regulates hepatocellular carcinoma cell proliferation, apoptosis, and mobility via targeting Fli-1-mediated Notch1 pathway.

Wang H, Lin X, Liu E, Jian Z, Ou Y. Wang H, et al. Among authors: jian z. J Cell Physiol. 2020 Oct;235(10):7635-7644. doi: 10.1002/jcp.29673. Epub 2020 Apr 2. J Cell Physiol. 2020. PMID: 32239672

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

997 results

Search Page

Filters